Lenvima (lenvatinib)

pCPA File Number: 21925

Negotiation Status:

Concluded with an LOI

Indication(s):

In combination with pembrolizumab, for the treatment of adult patients with advanced or metastatic renal cell carcinoma (RCC) with no prior systemic therapy for metastatic renal cell carcinoma (RCC)

Sponsor/Manufacturer:

Eisai Limited

CADTH Project Number:

PC0268

pCPA Engagement Letter Issued:

2022-10-21

Negotiation Process Concluded:

2023-05-10